FindTrial
Sign In

Effects of patient-controlled analgesia with hydromorphone or sufentanil on postoperative pulmonary complications in patients undergoing thoracic surgery

Effects of patient-controlled analgesia with hydromorphone or sufentanil on postoperative pulmonary complications in patients undergoing thoracic surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014282
Enrollment
Unknown
Registered
2018-01-03
Start date
2018-01-03
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic surgery

Interventions

Group A:hydromorphone for postoperative analgesia
Group B:sufentanil for Postoperative analgesia

Sponsors

Xinqiao Hospital affiliated to the Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Thoracic surgery, ASA I-II, aged 20~65 years, weight 45 to 80kg.

Exclusion criteria

Exclusion criteria: Patients with serious diseases of heart, liver, kidney, abnormal lung function or history of lung disease before operation.

Design outcomes

Primary

MeasureTime frame
postoperative pulmonary complications;—

Countries

China

Contacts

Public ContactLi Hong

Xinqiao Hospital affiliated to the Military Medical University

442479458@qq.com+86 13608380123

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026